Pharmacogenetic approaches to the treatment of alcohol addiction.
about
The pharmacology of neurokinin receptors in addiction: prospects for therapy15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuseThe relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humansBehavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disordersA model of alcohol drinking under an intermittent access schedule using group-housed micePatient-centered care interventions for the management of alcohol use disorders: a systematic review of randomized controlled trialsEffects of rearing conditions on behaviour and endogenous opioids in rats with alcohol access during adolescenceSubgroup Identification in Personalized Treatment of Alcohol Dependence.Don't stress about CRF: assessing the translational failures of CRF1antagonists.Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cuesRelaxin-3/RXFP3 system regulates alcohol-seeking.Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recoveryGenetic risk prediction and neurobiological understanding of alcoholism.Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects.Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings.Corticotropin releasing factor: a key role in the neurobiology of addictionHierarchical Naive Bayes for genetic association studiesAssociations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults.The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine studyUnwarranted optimism in media portrayals of genetic research on addiction overshadows critical ethical and social concerns.Transcriptome organization for chronic alcohol abuse in human brain.The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence.Effects of ampicillin on cystine/glutamate antiporter and glutamate transporter 1 isoforms as well as ethanol drinking in male P ratsAddiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic systemReceptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G PolymorphismEarly Life Stress, Nicotinic Acetylcholine Receptors and Alcohol Use Disorders.Involvement of Purinergic P2X4 Receptors in Alcohol Intake of High-Alcohol-Drinking (HAD) RatsThe genetics of addiction-a translational perspectiveThe genetics of alcohol dependence: advancing towards systems-based approaches.Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial.Medications development to treat alcohol dependence: a vision for the next decade.Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers.Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.Alcohol Consumption, Craving, and Craving Control Efforts Assessed Daily in the Context of Readiness to Change Among Individuals with Alcohol Dependence and PTSD.Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severityEffects of cocaine and withdrawal on the mouse nucleus accumbens transcriptome.Role of Ventral Subiculum in Context-Induced Relapse to Alcohol Seeking after Punishment-Imposed AbstinenceRole of a genetic polymorphism in the corticotropin-releasing factor receptor 1 gene in alcohol drinking and seeking behaviors of marchigian sardinian alcohol-preferring ratsKCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction.
P2860
Q26785438-348B925B-A880-4EC9-8F4D-8DB63D77E219Q26824667-71E7C404-BB9F-4A5F-ACEE-6E772F9A8101Q26992207-6D788493-ED44-4DAD-8724-6915E08E147DQ27014879-637067F0-C000-4E66-9662-C96FC1C05003Q27021285-9C3DBFC0-707C-4336-AD59-40827FC10D43Q27333982-8E9A1D39-1AB2-40BD-B74F-073652685420Q28068889-F4C0D707-33C6-41EB-BCE7-8C1661184E1AQ28533990-E7F91DB2-DE5D-43A2-B7E0-5786B0085802Q30279256-F84938AE-0B8F-4CEE-AEBD-496BF90A3FC1Q30399543-1B228766-D99C-402A-96F0-E24412E6491EQ30421563-B8666BAB-9C94-49C5-942A-54233D56D1D6Q30560386-060C5DFE-F3B6-4796-8F60-E2224CCB9A09Q33635582-9BA1C081-3CA5-4581-8F16-3E64BFF9150FQ33672725-C0B3C266-9251-4FDC-976F-33EAC9FF74C9Q33746846-763C56FC-CB2C-40BD-8967-C4AF541809A4Q34174792-2476DF84-F59E-4DB7-9796-616D49EF9610Q34421204-577F65A4-2BC8-406F-B8D9-635DFB9D5C41Q34457092-39C241AC-8A90-47AD-9C84-DB692640E8D8Q34989821-89ED15FE-555E-4EC5-8902-A2289E9E5544Q35200032-46D3014C-E105-40C8-A2D6-36A380BF77A2Q35671471-9F77E52C-CE22-4102-8DA1-E31F1F495499Q35674997-EF6F2501-C2C6-46E2-9D41-B2DA6BE53493Q35813107-028E2D78-E195-4150-9F6B-63D9AF2DD8AEQ35863999-8EDEBD54-1682-47F3-A2FC-D5BD4EDE2FB0Q35995415-5758C29D-73C4-45E8-B842-E00A1D6980F6Q36059914-7CBEDC68-8142-4C61-9F0E-AC5DAE12AFBFQ36105732-8C7E02B4-48C0-42A2-8890-A3B230352E87Q36117771-E9C960BA-7D44-46D6-8DAE-863452F52009Q36135947-2F6CF36E-93A4-4972-ADFA-001F83A64B3EQ36314812-72A694D3-8A88-40FB-BA00-6AB5B2618284Q36342939-54858A57-FACF-40A1-BD0C-328F67C35083Q36357552-88700777-E289-44A9-8D33-8C97A28ADDC7Q36363819-34623FC2-B934-48C7-AF49-C10239B6B9A2Q36390400-6779E069-9F20-4961-9EC8-B981EEEFD40DQ36414641-1CE48367-76FA-476C-87A1-DF4F4CCD59FDQ36542339-B666B029-8D39-49B7-9D40-73696BDD9DD3Q36557104-9EF33AD8-6B6F-440D-8151-D5C972C84211Q36690137-1774C306-70A5-4C9D-A26C-A52E07D73A75Q36759548-D5EB4382-1E91-4ABF-97C2-847188599BA9Q36821781-F34FC34A-2140-4988-B6CB-F27B3FDC80D3
P2860
Pharmacogenetic approaches to the treatment of alcohol addiction.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pharmacogenetic approaches to the treatment of alcohol addiction.
@ast
Pharmacogenetic approaches to the treatment of alcohol addiction.
@en
type
label
Pharmacogenetic approaches to the treatment of alcohol addiction.
@ast
Pharmacogenetic approaches to the treatment of alcohol addiction.
@en
prefLabel
Pharmacogenetic approaches to the treatment of alcohol addiction.
@ast
Pharmacogenetic approaches to the treatment of alcohol addiction.
@en
P2860
P356
P1476
Pharmacogenetic approaches to the treatment of alcohol addiction.
@en
P2093
Charles P O'Brien
Wade Berrettini
P2860
P2888
P304
P356
10.1038/NRN3110
P407
P577
2011-10-20T00:00:00Z